Nutex Health (NUTX) Capital Leases (2021 - 2026)

Nutex Health has disclosed Capital Leases across 6 years of filings, most recently posting $268.8 million for Q1 2026.

• Capital Leases for Q1 2026 came in at $268.8 million, up 4.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $268.8 million (up 4.02% YoY), and the FY2025 annual result was $268.9 million, up 3.62% from the prior year.
• Capital Leases came in at $268.8 million for Q1 2026 at Nutex Health, roughly flat from $268.9 million in the prior quarter.
• In the past five years, Capital Leases ranged from a high of $270.1 million in Q3 2025 to a low of $192.5 million in Q2 2022.
• The 5-year median for Capital Leases is $233.9 million (2024), against an average of $236.5 million.
• Across the five-year window, Capital Leases jumped 209.76% in 2022 and retreated 8.67% in 2024, its largest moves.
• Nutex Health's Capital Leases stood at $203.6 million in 2022, then climbed by 5.04% to $213.9 million in 2023, then advanced by 21.32% to $259.5 million in 2024, then rose by 3.62% to $268.9 million in 2025, then declined by 0.04% to $268.8 million in 2026.
• The last three Capital Leases figures came in at $268.8 million (Q1 2026), $268.9 million (Q4 2025), and $270.1 million (Q3 2025), per Business Quant data.